These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 31575873

  • 21. Solubility shift and SUMOylaltion of promyelocytic leukemia (PML) protein in response to arsenic(III) and fate of the SUMOylated PML.
    Hirano S, Tadano M, Kobayashi Y, Udagawa O, Kato A.
    Toxicol Appl Pharmacol; 2015 Sep 15; 287(3):191-201. PubMed ID: 26049103
    [Abstract] [Full Text] [Related]

  • 22. Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3.
    Evdokimov E, Sharma P, Lockett SJ, Lualdi M, Kuehn MR.
    J Cell Sci; 2008 Dec 15; 121(Pt 24):4106-13. PubMed ID: 19033381
    [Abstract] [Full Text] [Related]

  • 23. SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML.
    Fasci D, Anania VG, Lill JR, Salvesen GS.
    Sci Signal; 2015 Jun 09; 8(380):ra56. PubMed ID: 26060329
    [Abstract] [Full Text] [Related]

  • 24. Comparison of the SUMO1 and ubiquitin conjugation pathways during the inhibition of proteasome activity with evidence of SUMO1 recycling.
    Bailey D, O'Hare P.
    Biochem J; 2005 Dec 01; 392(Pt 2):271-81. PubMed ID: 16117725
    [Abstract] [Full Text] [Related]

  • 25. FAT10, a ubiquitin-independent signal for proteasomal degradation.
    Hipp MS, Kalveram B, Raasi S, Groettrup M, Schmidtke G.
    Mol Cell Biol; 2005 May 01; 25(9):3483-91. PubMed ID: 15831455
    [Abstract] [Full Text] [Related]

  • 26. Activating the ubiquitin family: UBA6 challenges the field.
    Groettrup M, Pelzer C, Schmidtke G, Hofmann K.
    Trends Biochem Sci; 2008 May 01; 33(5):230-7. PubMed ID: 18353650
    [Abstract] [Full Text] [Related]

  • 27. Parkin is an E3 ligase for the ubiquitin-like modifier FAT10, which inhibits Parkin activation and mitophagy.
    Roverato ND, Sailer C, Catone N, Aichem A, Stengel F, Groettrup M.
    Cell Rep; 2021 Mar 16; 34(11):108857. PubMed ID: 33730565
    [Abstract] [Full Text] [Related]

  • 28. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
    Coey CT, Fitzgerald ME, Maiti A, Reiter KH, Guzzo CM, Matunis MJ, Drohat AC.
    J Biol Chem; 2014 May 30; 289(22):15810-9. PubMed ID: 24753249
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation.
    Hipp MS, Raasi S, Groettrup M, Schmidtke G.
    J Biol Chem; 2004 Apr 16; 279(16):16503-10. PubMed ID: 14757770
    [Abstract] [Full Text] [Related]

  • 31. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
    Citro S, Chiocca S.
    Methods Mol Biol; 2017 Apr 16; 1510():329-337. PubMed ID: 27761832
    [Abstract] [Full Text] [Related]

  • 32. Identification of proximal SUMO-dependent interactors using SUMO-ID.
    Barroso-Gomila O, Trulsson F, Muratore V, Canosa I, Merino-Cacho L, Cortazar AR, Pérez C, Azkargorta M, Iloro I, Carracedo A, Aransay AM, Elortza F, Mayor U, Vertegaal ACO, Barrio R, Sutherland JD.
    Nat Commun; 2021 Nov 18; 12(1):6671. PubMed ID: 34795231
    [Abstract] [Full Text] [Related]

  • 33. Structure of UBE2Z Enzyme Provides Functional Insight into Specificity in the FAT10 Protein Conjugation Machinery.
    Schelpe J, Monté D, Dewitte F, Sixma TK, Rucktooa P.
    J Biol Chem; 2016 Jan 08; 291(2):630-9. PubMed ID: 26555268
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation.
    Aichem A, Anders S, Catone N, Rößler P, Stotz S, Berg A, Schwab R, Scheuermann S, Bialas J, Schütz-Stoffregen MC, Schmidtke G, Peter C, Groettrup M, Wiesner S.
    Nat Commun; 2018 Aug 20; 9(1):3321. PubMed ID: 30127417
    [Abstract] [Full Text] [Related]

  • 36. Arkadia/RNF111 is a SUMO-targeted ubiquitin ligase with preference for substrates marked with SUMO1-capped SUMO2/3 chain.
    Sriramachandran AM, Meyer-Teschendorf K, Pabst S, Ulrich HD, Gehring NH, Hofmann K, Praefcke GJK, Dohmen RJ.
    Nat Commun; 2019 Aug 15; 10(1):3678. PubMed ID: 31417085
    [Abstract] [Full Text] [Related]

  • 37. Respiratory syncytial virus induces NRF2 degradation through a promyelocytic leukemia protein - ring finger protein 4 dependent pathway.
    Komaravelli N, Ansar M, Garofalo RP, Casola A.
    Free Radic Biol Med; 2017 Dec 15; 113():494-504. PubMed ID: 29107745
    [Abstract] [Full Text] [Related]

  • 38. The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10.
    Schmidtke G, Kalveram B, Weber E, Bochtler P, Lukasiak S, Hipp MS, Groettrup M.
    J Biol Chem; 2006 Jul 21; 281(29):20045-54. PubMed ID: 16707496
    [Abstract] [Full Text] [Related]

  • 39. The ubiquitin-like modifier FAT10 in antigen processing and antimicrobial defense.
    Basler M, Buerger S, Groettrup M.
    Mol Immunol; 2015 Dec 21; 68(2 Pt A):129-32. PubMed ID: 25983082
    [Abstract] [Full Text] [Related]

  • 40. SUMO, Ubiquitin, UBL Proteins: Implications For Human Diseases - Fifth International Conference.
    Skaug B, Chen ZJ.
    IDrugs; 2010 Apr 21; 13(4):224-7. PubMed ID: 20373248
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.